Physician profile
Natasha A Bower
NPI 1689892176
$2,008.17
in general payments reported to CMS, 2019-2025
26 companies · $525 in 2025
The $525 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $240 · 2020: $80.36 · 2021: $338 · 2022: $215 · 2023: $347 · 2024: $263 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,135.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,134.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $292.04 | 2019-2025 | Liletta |
| Hologic Sales and Service, LLC | $248.34 | 2019-2025 | Aptima |
| Sumitomo Pharma America, INC. | $181.51 | 2023-2025 | Myfembree |
| Mayne Pharma Commercial LLC | $173.04 | 2021-2025 | |
| Pfizer INC. | $166.20 | 2019-2025 | |
| Exeltis, USA INC. | $148.07 | 2022-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $127.30 | 2019-2025 | |
| Astellas Pharma US INC | $117.10 | 2019-2025 | Veozah |
| Organon LLC | $94.78 | 2023-2025 | Nexplanon, Jada System |
| Biogen, INC. | $62.37 | 2024-2025 | Zurzuvae |
| Merck Sharp & Dohme LLC | $48.63 | 2021-2023 | Gardasil 9 |
| Therapeuticsmd, INC. | $35.49 | 2020-2022 | |
| Coopersurgical, INC. | $34.85 | 2021-2024 | Paragard T 380a |
| Covidien LP | $31.32 | 2019 | |
| Amgen INC. | $30.95 | 2019-2025 | Evenity |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $30.74 | 2021 | |
| Urovant Sciences INC | $26.58 | 2022 | |
| Mycovia Pharmaceuticals, INC. | $25.92 | 2023 | Vivjoa |
| Boston Scientific Corporation | $23.78 | 2019 | |
| Daiichi Sankyo INC. | $18.54 | 2022 | |
| Axonics, INC. | $18.37 | 2022 | |
| Duchesnay USA Incorporated | $17.59 | 2019 | |
| Myovant Sciences INC. | $16.55 | 2022 | |
| Cumberland Pharmaceuticals, INC. | $13.84 | 2021 | |
| Medtronic, INC. | $12.68 | 2022 | |
| Medicem INC. | $11.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Natasha Bower listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.